09/01/2024 BlogNewsOtherStem Cell News
Stem Cell Blog
Употребата на матичните клетки од папочна врвца рапидно се зголемува. Пред 10 години крвта од папочна врвца можеше да лекува околу 40 состојби, но денес таа бројка е над 80. Со нетрпение очекуваме нови терапии за болести и нарушувања како што се дијабет, аутизам и мозочен удар, можете да бидете во тек со најновите случувања во регенеративната медицина на нашиот блог за матични клетки.
09/01/2024 BlogOtherStem Cell News
A Phase II trial investigating the use of umbilical cord blood mesenchymal stem cells (MSCs) to treat bronchopulmonary dysplasia (BPD) in premature infants has shown promising initial results, giving way to a larger Phase II study, focusing on a subset of babies who looked to have benefitted most from the therapy.
08/01/2024 BlogNewsPregnancy AdviceStem Cell News
To kick off the new year, we’ve taken a look back at some of the many cord blood developments of 2018 and a look forward to what 2019 could hold. Here is our stem cell timeline…
02/01/2024 BlogNewsStem Cell NewsUses for Placenta
A US hospital has become the first hospital in the nation to use a placenta-based cell-therapy to treat COVID-19 patients, which has resulted in the coronavirus-recovered patients heading home.
Holy name is the first in the US to use the latest placenta-based cell-therapy from Pluristem. The treatment uses cells from the placenta which is then injected into the arms and legs of the patient. A 49-year-old COVID-19 patient on a ventilator, was one of the first patients without organ failure to receive the placenta cell treatment.
02/01/2024 BlogStem Cell NewsUses for Placenta
According to new research, an injection of cells from the placenta can ease the pain and other symptoms of arthritis sufferers for up to one year.
The new treatment, ReNu, developed by British-US-based firm Organogensis, is made from cells of the innermost layer of the placenta, the amnion, which is donated at childbirth.
02/01/2024 NewsStem Cell NewsUses for Placenta
The placenta could hold the key to treating premature babies suffering from chronic lung disease, thanks to a clinical trial taking place in Australia.
Doctors at Monash Children’s Hospital, Victoria are using placenta stem cells in their trial, as a way of combatting the effects of bronchopulmonary dysplasia (BPD).
02/01/2024 BlogNewsStem Cell NewsUses for Placenta
A small cohort of six critically ill COVID-19 patients hospitalised in Israel have been treated with a placenta-based cell-therapy and have all survived, according to initial data.
Last week we held a live webinar to celebrate the last day of Cord Blood Awareness Month. We thoroughly enjoyed chatting to you all to help raise awareness of umbilical cord blood.
What is regenerative medicine?
The concept of “regenerative medicine” was coined in 1999, encompassing a field of scientific innovations aimed at repairing, regrowing, and potentially replacing cells, tissues, and organs damaged by disease in the human body. This groundbreaking field includes advancements such as cord blood therapy.
The outbreak of a new coronavirus, COVID-19, has prompted many expectant parents to wonder whether it can pass from mother to child during pregnancy. Until recently, limited information was available regarding the effects of COVID-19 on pregnant women and their babies, however initial studies appear to be positive.
Cells4Life Group LLP,
Units 2-3 Oak House, Woodlands Office Park,
Albert Drive, Burgess Hill, RH15 9TN, UK.
Med Bio Genetics
Pero Nakov 110, Skopje, Republic Macedonia
+389 70 221 602
info@cells4life.mk
